SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (9633)12/2/2003 3:44:18 PM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
Yes those PNH results do look good, but I'm guessing 11 patients do not an approval make. (Although another 20 would probably do it). Has there been any talk of a pivotal trial?

Of course it's an exceedingly rare disease, so not sure if it's enough to save ALXN all by itself unless they go the GENZ unconscionable pricing route.

Peter